Form 4: SeaStar Medical Chief Medical Officer Acquires Shares and Restricted Stock Units

SeaStar Medical's Chief Medical Officer, Kevin Chung, acquired 4,250 shares of common stock and 15,000 restricted stock units.

Summary

• Kevin Chung, the Chief Medical Officer of SeaStar Medical Holding Corporation, reported a transaction involving the company's stock.
• On November 18, 2024, Mr. Chung purchased 4,250 shares of common stock at a price of $1.99 per share.
• Following this purchase, Mr. Chung directly owns 13,685 shares of common stock.
• Additionally, on November 15, 2024, Mr. Chung was granted 15,000 restricted stock units (RSUs).
• These RSUs will vest in equal installments over three years, starting on July 1, 2025.

Sentiment

Score: 6

Explanation: The document reflects a routine insider transaction. The purchase of shares and grant of RSUs are generally positive signals, but this is a standard filing and not a major event.

Positives

• The acquisition of shares by a key executive may signal confidence in the company's future prospects.
• The granting of RSUs aligns the executive's interests with the long-term performance of the company.

Future Outlook

The vesting of the restricted stock units over the next three years suggests a long-term commitment from the executive.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Insider transactions are a common occurrence in publicly traded companies, and the reporting of these transactions via SEC Form 4 is standard practice.
• The vesting schedule of the RSUs is typical for executive compensation packages, aligning with industry norms for incentivizing long-term performance.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.

Key Dates

Keywords

SeaStar Medical, ICU, Kevin Chung, Chief Medical Officer, stock acquisition, restricted stock units, RSU, insider trading, beneficial ownership